基于OpenFDA挖掘与评价达格列净上市后的不良反应
林忠秋, 陈俊, 黄振光, 丘岳, 张宏亮
Analysis of post-marketing adverse drug reactions induced by dapagliflozin based upon OpenFDA
LIN Zhong-qiu, CHEN Jun, HUANG Zhen-guang, QIU Yue, ZHANG Hong-liang
中国医院药学杂志
.
2021, (20): 2095
-2098,2120
.
DOI: 10.13286/j.1001-5213.2021.20.10
